HCAT
Health Catalyst Inc
1.80$
+2.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 56.6% | 59.4% | 51.5% | 52.8% | 55.4% | 56.4% | 54.4% | 52.6% | 50.5% | 47.3% | 66.6% | 50.5% | 53.6% | |
| 43.4% | 40.6% | 48.5% | 47.2% | 44.6% | 43.6% | 45.6% | 47.4% | 49.5% | 52.7% | 33.4% | 49.5% | 46.4% | |
| 23.9% | 27.0% | 19.9% | 18.3% | 18.6% | 18.8% | 19.1% | 15.4% | 16.1% | 13.3% | 13.7% | 15.6% | 14.7% | |
| 16.2% | 20.6% | 19.5% | 18.9% | 16.0% | 19.7% | 17.8% | 10.3% | 21.1% | 8.1% | 19.7% | 16.9% | 16.4% | |
| 76.7% | 84.3% | 79.0% | 68.0% | 62.5% | 65.6% | 71.0% | 93.3% | 72.5% | 48.4% | 43.0% | 101.2% | 66.1% | |
| -33.3% | -43.7% | -30.5% | -20.8% | -17.9% | -22.0% | -25.4% | -46.0% | -22.9% | 4.4% | -9.5% | -51.8% | -19.7% | |
| 2.5% | 2.4% | 2.4% | 2.4% | 8.0% | 9.2% | 9.2% | 7.2% | 7.4% | 7.4% | 6.7% | 6.6% | 7.0% | |
| -29.8% | -40.2% | -27.4% | -17.7% | -19.9% | -25.2% | -29.6% | -50.7% | -29.1% | -121.4% | -156.3% | -57.1% | -90.2% | |
| 0.1% | 0.2% | 0.2% | 0.1% | -0.6% | 0.8% | 0.3% | 0.1% | 0.1% | 0.5% | 0.6% | 0.4% | 0.4% | |
| -29.9% | -40.4% | -27.6% | -17.8% | -19.3% | -26.0% | -29.9% | -50.8% | -29.1% | -121.9% | -156.9% | -57.5% | -90.6% | |
| -12.5% | -24.0% | -10.9% | -1.3% | -8.8% | -3.1% | -4.9% | -27.8% | -5.2% | -96.7% | -132.5% | -24.3% | -64.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.